Related Experiment Video
Updated: Jul 14, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART
Insights
HIV patients on HAART show elevated NT-proBNP levels compared to blood donors, indicating potential cardiac strain. This finding supports increased cardiovascular event risk in HIV-infected individuals.
Area of Science:
- Cardiology
- Infectious Diseases
- Biomarkers
Background:
- Highly active anti-retroviral therapy (HAART) improves survival in HIV patients.
- HIV-infected individuals face increased cardiovascular complications.
- N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a cardiac function indicator.
Purpose of the Study:
- To compare NT-proBNP levels in HIV patients on HAART versus healthy blood donors.
- To investigate the relationship between NT-proBNP levels and cardiovascular risk factors in HIV patients.
Main Methods:
- Analyzed NT-proBNP levels in 495 HIV patients on HAART and 1980 blood donors using an electrochemiluminescence immunoassay (ECLIA).
- Compared NT-proBNP levels across different age groups and genders.
- Assessed correlations with cardiovascular risk factors, including GFR and CRP.
Main Results:
- HIV patients exhibited significantly higher NT-proBNP levels than age-matched blood donors across most age groups.
- Elevated NT-proBNP was observed consistently across age and gender groups.
- NT-proBNP levels did not correlate with most cardiovascular risk factors in HIV patients, except for CRP.
- No evidence of cardiotoxicity from HAART or specific antiretroviral drugs was found.
- High NT-proBNP levels were noted in Hepatitis C virus (HCV) patients treated with alpha-interferon.
Conclusions:
- HIV patients on HAART have elevated NT-proBNP, suggesting increased cardiac strain.
- Higher prevalence of cardiovascular and HIV-associated risk factors may contribute to elevated NT-proBNP.
- Findings align with increased cardiovascular event incidence in HIV-infected individuals.
- Further research is needed to link NT-proBNP levels to cardiovascular outcomes in HIV.
Background:
Studies suggest that highly active anti-retroviral therapy (HAART) prolongs life in HIV infected individuals and that HIV infected individuals increasingly suffer from cardiovascular complications. NT-proBNP has been shown to represent an indicator of cardiac function.
Methods:
495 HIV infected individuals under HAART and 1980 blood donors (BD) were tested for N-terminal pro-B-type natriuretic peptide (NT-proBNP). NT-proBNP was performed by an automated electrochemiluminescence immunoassay (ECLIA) method.
Results:
HIV infected individuals had significantly higher NT-proBNP levels than age matched blood donors (18-29 y: median: 33 pg/ml HIV vs. 5 pg/ml BD; p = 0.0247; 30-39 y: median: 25 pg/ml HIV vs. 5 pg/ml BD; p = 0.0351; 40-49 y: median: 35.5 pg/ml HIV vs. 5 pg/ml BD; p < 0.0001; 50-59 y: median: 42 pg/ml HIV vs. 36 pg/ml BD; p = 0.3665; 60-69 y: median: 82.5 pg/ml HIV vs. 46 pg/ml BD; p = 0.0055) the effect was consistently found in all age and both gender groups. HIV infected individuals differed from the blood donor control group with respect to cardiovascular risk factors (hypertension, cardiovascular (CV) medication, diabetes mellitus, smoking status). In HIV infected individuals NT-proBNP levels did not correlate to cardiovascular risk factors including GFR except for C-reactive protein (CRP) levels using multivariate analysis. There was also no evidence for cardiotoxic effects due to HAART or specific antiretroviral drugs. High NT-proBNP levels were found in Hepatitis C virus (HCV) infected individuals who had received alpha-interferon therapy.
Conclusions:
HIV infected individuals had higher NT-proBNP levels than age matched blood donors possibly as a result of a higher prevalence of general cardiovascular risk factors and HIV associated risk factors, the finding is consistent with an increased incidence of cardiovascular events described in HIV infected individuals. Further studies on the relationship to cardiovascular outcome are warranted.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
08:33Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Inhibitors of Virion Maturation and Assembly
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Antiviral Nucleoside Inhibitors